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Synopsis ....................................
Medical records for 572 patients in two extended
care facilities were reviewed to study seizure
disorders and antiepileptic drug use. Seventy pa-
tients (12.2 percent) were receiving antiepileptic
drugs. Of this group, 43 patients (61.4 percent)
had a diagnosis of epilepsy or documented sei-
zures, 2 were being treated for neuralgia, and 25
(35.7 percent) had no reason given for antiepileptic
use. The most common cause was cerebrovascular
accident (38.9 percent), and no associated etiology
was found in 29.2 percent. Phenytoin was the
most commonly used agent. Thirty-two (45.7 per-
cent) were taking two or more antiepileptic drugs.
Thirteen patients had had no serum concentration
monitoring in the last year. Thirty-seven patients
(52.9 percent) had had at least one serum concen-
tration outside of the therapeutic range.
T HE NEED TO MINIMIZE DRUG USE by the elderly
and avoid the risk of toxicity and drug-related
costs is a frequent theme in articles about drug use
among the elderly (1,2). The antiepileptic drugs are
potentially toxic and require therapeutic drug mon-
itoring, adding to the cost of drug therapy (3).
Limited information about antiepileptic drug use
in extended care facilities indicates that, for more
than one-third of patients, there was no docu-
mented reason to use these drugs (4,5). In describ-
ing inappropriate use of antiepileptic drugs,
Moseley and Penry discussed inadequate doses,
lack of therapeutic drug monitoring, administra-
tion of antiepileptic drugs on an "as needed"
basis, and the use of intramuscular phenytoin
which is erratically absorbed (4). We reviewed
medical records of patients in two extended care
facilities to evaluate use of antiepileptic drugs.
Methods
Two extended care facilities for skilled and
intermediate care patients (facilities A and B) were
selected for review of all medical records of
patients present at the facilities on a single day in
September 1982. Data collected from a retrospec-
tive review of all patients receiving antiepileptic
drugs included documentation of a seizure or
suspected seizure disorder; documentation of other
possible reasons for using the drugs; possible
etiologies for seizures; age and sex of the patient;
the names, numbers, and doses of antiepileptic
agents used; and results of serum concentration
monitoring within the past year.
In a second study, medical records of all
patients who received antiepileptic drugs in 1982
were reviewed at facility A. Patients who had
antiepileptic therapy discontinued were monitored
for recurrence of seizures and reinstitution of
antiepileptic drugs. Following consultation between
the physician responsible for the patients and a
clinical pharmacist, antiepileptic agents were dis-
continued in additional patients, and these patients
were monitored prospectively.
Results
A total of 572 patients' records were reviewed,
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Table 1. Use of antiepileptic drugs among
extended care facilities, 1982
patients at 2
Facility Facility
Characteristics of patients A B Total
Total number of patients ....... ..... 215 357 572
Total number on antiepileptic drugs . 23 47 70
1 drug ........................... 10 28 38
2 drugs .......................... 9 18 27
3 drugs .......................... 4 1 5
Mean age (years) ................... 64.2 67.8 66.0
Table 2. Etiology of seizures or associated risks for patients
receiving antiepileptic drugs
Reason for prescription Number Percent
Cerebrovascular accident1 ......... 28 38.9
Unknown ......................... 21 29.2
Alcoholism ........................ 7 9.7
Other ........................... 7 9.7
Cerebrovascular disease ........... 5 6.9
Head trauma ...................... 2 2.8
Meningitis ........................ 2 2.8
1 Diagnoses listed in medical chart.
NOTE: Several patients had more than 1 possible etiology listed.
Table 3. Serum concentration monitoring of patients receiv-
ing antiepileptic drugs at 2 extended care facilities, 1982
Number of serum concentrations
Normal range
Drug (mcg per ml) Toxic Therapeutic Subtherapeutic
Phenytoin ....... 10-20 31 31 24
Phenobarbital .... 10-30 2 21 3
Primidone ....... 5-12 0 1 0
Carbamazepine.. 4-12 0 0 3
Valproic acid..... 50-150 2 0 0
NOTE: 13 patients were not monitored.
215 from facility A and 357 from facility B.
Seventy (12.2 percent) were receiving antiepileptic
drugs, of whom 23 (10.7 percent) were from
facility A and 47 (13.2 percent) from facility B.
Mean age of patients receiving these drugs was
66.0 years.
Of the 70 patients administered antiepileptic
drugs, 38 (54.3 percent) were taking one agent, 27
(38.6 percent) two drugs, and five (7.1 percent)
were taking three or more drugs simultaneously
(table 1). Forty-three patients (61.4 percent) had a
diagnosis of epilepsy or seizures documented in
their medical charts. Two other patients had a
diagnosis of neuralgia as the reason for treatment.
Twenty-five patients (35.7 percent) had no docu-
mented seizure occurrence or diagnoses (such as
neuralgia) related to use of antiepileptic medica-
tion. The etiologies for seizures or associated risks
for seizures are described in table 2. The most
common cause was cerebrovascular accident (38.9
percent). No associated causes or major risk
factors for seizures were found in 21 patients.
The various drugs used follow:





Valproic acid ......................... 3
Although phenytoin was the most commonly
used antiepileptic agent, it was the drug with the
most dosing problems as reflected by the small
number of serum concentrations which fell into the
therapeutic range (31 or 36.0 percent of all
phenytoin concentrations).
Information about the serum concentration
monitoring of patients receiving antiepileptic drugs
is reviewed in table 3. Thirteen patients (18.6
percent) received no serum level monitoring at all.
A total of 118 drug concentration measurements
were made for the remaining 57 patients. Forty-
one of the 70 patients (58.6 percent) had at least
one serum concentration in the therapeutic range,
20 patients (28.6 percent) had at least one serum
concentration in the toxic range, and 17 (24.3
percent) had at least one subtherapeutic serum
concentration. Only 53 (44.9 percent) of the
measurements were within their recommended ther-
apeutic ranges. Thirty-seven patients (52.9 percent)
had at least one serum concentration outside of
the therapeutic range.
Details of drug discontinuation are in table 4.
Eighteen patients at facility A were tapered off
antiepileptic drugs for clinical reasons. A major
indication for discontinuing was the absence of
seizures during subtherapeutic antiepileptic ther-
apy. Some of the patients with cerebrovascular
accidents were started on antiepileptic agents pro-
phylactically since seizures had never been docu-
mented. No seizures were noted in the charts
during the followup, although one patient was
restarted on phenytoin because of the family's
request. One of the four patients followed less
than 6 months died within a month. Other patients
not followed longer than a year entered other
facilities or hospitals or returned home.
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Discussion
As noted by Moseley and Penry (4), there is a
lack of documentation in the medical records of
extended care facilities regarding the rationale for
use of antiepileptic drugs. In their 1975 study, 17
of 44 patients on antiepileptic drugs (38.6 percent)
were found to have no history of epilepsy nor of
seizures observed or documented. Our study
showed that 25 of 70 records (35.7 percent) had no
mention of a seizure disorder. These data, col-
lected 8 years later, are remarkably similar.
This study does not address the possibility that
elderly patients who have a seizure disorder were
undiagnosed or untreated. Seizures may be misdi-
agnosed as cardiac syncope, transient ischemic
attacks, Meniere's disease, or psychiatric disorders,
depending on the clinical presentation. In fact,
periodic lateralized epileptiform discharges are as-
sociated with prolonged episodes of confusion in
elderly patients (6).
Unlike the earlier studies (4,5) the appropriate-
ness of dosing could be evaluated since most
patients had therapeutic drug level monitoring.
Twenty patients were in the toxic range on at least
one occasion (35 toxic serum concentrations during
the preceding 12 months), and 17 patients had 30
subtherapeutic levels within the preceding 12
months. While a few patients require serum con-
centrations either above or below the therapeutic
range for optimum seizure control, the majority
will be most appropriately treated by "therapeu-
tic" concentrations. Intramuscular phenytoin was
used when a patient had a seizure. This is an
inappropriate use since intramuscular phenytoin is
erratically absorbed; the onset of effect for oral
phenytoin would be more rapid (7). "Prn" or "as
needed" antiepileptic drug use was not noted.
Since seizure type was often not well-described
and EEG information lacking, it was impossible to
determine whether the most appropriate drug had
been selected for those patients with documented
seizures. Phenytoin and phenobarbital were rou-
tinely used while the newer agents, carbamazepine
and valproic acid, were rarely the drug of first
choice. In younger patients, the discontinuation of
these sedative-type antiepileptic agents and substi-
tution with carbamazepine and valproic acid has
resulted in fewer side effects for many patients (8).
The most common etiology of seizures was
cerebrovascular accident (38.9 percent), and these
patients formed 70.6 percent of the group success-
fully discontinued from antiepileptic drugs. Eleven
of 44 patients (25.0 percent) in Moseley and






Diagnosis of cerebrovascular accident.......... 12
Seizures documented in medical chart ......... 8
No seizures documented in medical chart ...... 10
Prescribed phenytoin .......... ............... 17
Successfully discontinued ........ ............. 18
Serum concentrations of drugs:





6 months .................................... 4
6-12 months .................. 4
12 months .......................... . 9
Penry's population (4) had cerebrovascular acci-
dents. The literature is unclear about the indica-
tions for and recommended length of antiepileptic
prophylaxis following cerebrovascular accidents.
However, these data indicate a need for reevalua-
tion of chronic antiepileptic drug use in this
population. Discontinuation of unnecessary anti-
epileptic drugs may be particularly helpful in
reducing unnecessary medication with its attendent
costs and drug toxicity in institutionalized patients.
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